Georg Damm

5.7k total citations · 2 hit papers
68 papers, 2.7k citations indexed

About

Georg Damm is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Georg Damm has authored 68 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 25 papers in Molecular Biology and 14 papers in Epidemiology. Recurrent topics in Georg Damm's work include Liver physiology and pathology (27 papers), Liver Disease Diagnosis and Treatment (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Georg Damm is often cited by papers focused on Liver physiology and pathology (27 papers), Liver Disease Diagnosis and Treatment (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Georg Damm collaborates with scholars based in Germany, United States and Sweden. Georg Damm's co-authors include Daniel Seehofer, Katrin Zeilinger, Nora Freyer, Fanny Knöspel, Andreas K. Nüssler, Victoria Kegel, Jan G. Hengstler, Maria Thomas, Ulrich M. Zanger and Davide Povero and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Georg Damm

66 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multilineage communication regulates human liver bud development from pluripotency

2017 424 citations J. Gray Camp, Georg Damm et al. profile →
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

2020 405 citations Georg Damm, Daniel Seehofer et al. profile →

Peers

Countries citing papers authored by Georg Damm

Since Specialization

Citations

This map shows the geographic impact of Georg Damm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Damm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Damm more than expected).

Fields of papers citing papers by Georg Damm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Damm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Damm. The network helps show where Georg Damm may publish in the future.

Co-authorship network of co-authors of Georg Damm

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Damm. A scholar is included among the top collaborators of Georg Damm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Damm. Georg Damm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation and Distinction of Energy Metabolism in Proliferating Hepatocytes and Hepatocellular Carcinoma Cells 2025 ·Cells ·(unknown), (unknown), (unknown), Jan‐Heiner Küpper, Daniel Seehofer, Georg Damm	1
2	Fluoride intake during pregnancy: calculation of realistic exposure scenarios for individual risk assessment 2025 ·Archives of Toxicology ·(unknown), Monika Batke, Georg Damm, Heidi Foth, Alexius Freyberger, Jan G. Hengstler, Aswin Mangerich, Falko Partosch, Thomas Schupp, Klaus‐Michael Wollin, (unknown), Ursula Gundert‐Remy	0
3	Cell atlas of the regenerating human liver after portal vein embolization 2024 ·Nature Communications ·Agnieska Brazovskaja, Tomás Gomes, René Holtackers, Philipp Wahle, Christiane Körner, Zhisong He, (unknown), (unknown), (unknown), Małgorzata Santel, Makiko Seimiya, Timm Denecke, Michael Dannemann, Mario Brosch, Jochen Hampe, Daniel Seehofer, Georg Damm, J. Gray Camp, Barbara Treutlein	5
4	A new human autologous hepatocyte/macrophage co-culture system that mimics drug-induced liver injury–like inflammation 2024 ·Archives of Toxicology ·(unknown), (unknown), (unknown), (unknown), (unknown), Sabrina Ehnert, (unknown), (unknown), Achim Aigner, Susanne Schiffmann, Andreas K. Nüssler, Daniel Seehofer, Georg Damm	2
5	Immuno-inflammatory in vitro hepatotoxicity models to assess side effects of biologicals exemplified by aldesleukin 2023 ·Frontiers in Immunology ·(unknown), (unknown), Nicole Ziegler, Dominique Thomas, (unknown), Georg Damm, (unknown), Philip Hewitt, Michael J. Parnham, Susanne Schiffmann	5
6	Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses 2020 ·PLoS Pathogens ·(unknown), Tim Maiwald, Marcel Schilling, Annette Schneider, Joschka Willemsen, (unknown), (unknown), Clemens Kreutz, Christian Ehlting, Jun Huang, Sajib Chakraborty, Xiaoyun Huang, Georg Damm, Daniel Seehofer, Philipp A. Lang, Johannes G. Bode, Marco Binder, Ralf Bartenschlager, Jens Timmer, Ursula Klingmüller	6
7	Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction 2020 ·Molecular Systems Biology ·(unknown), Marcus Rosenblatt, (unknown), (unknown), Vladimir Gonçalves Magalhães, Christopher Dächert, Tim Maiwald, (unknown), (unknown), (unknown), Katrin Hoffmann, Georg Damm, Daniel Seehofer, Tobias Boettler, Marco Binder, Jens Timmer, Marcel Schilling, Ursula Klingmüller	34
8	Critical evaluation of human health risks due to hydraulic fracturing in natural gas and petroleum production 2020 ·Archives of Toxicology ·Klaus‐Michael Wollin, Georg Damm, Heidi Foth, Alexius Freyberger, Thomas Gebel, Aswin Mangerich, Ursula Gundert‐Remy, Falko Partosch, Claudia Röhl, Thomas Schupp, Jan G. Hengstler	44
9	<p>Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system</p> 2019 ·Drug Design Development and Therapy ·Nora Freyer, Fanny Knöspel, Georg Damm, Selina Greuel, (unknown), Daniel Seehofer, Thomas Stöhr, Karl‐Uwe Petersen, Katrin Zeilinger	45
10	Imatinib and spironolactone suppress hepcidin expression 2017 ·Haematologica ·Katarzyna Mleczko‐Sanecka, (unknown), (unknown), (unknown), (unknown), Georg Damm, Daniel Seehofer, Martina U. Muckenthaler	22
11	Primary‐like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures 2015 ·Cell Biology International ·(unknown), Max Hansen, (unknown), Kai‐Uwe Schmidtke, Ursula Anderer, Amelie Lupp, (unknown), Daniel Seehofer, Georg Damm, Katrin Scheibner, Jan‐Heiner Küpper	26
12	High exposure to inorganic arsenic by food: the need for risk reduction 2015 ·Archives of Toxicology ·Ursula Gundert‐Remy, Georg Damm, Heidi Foth, Alexius Freyberger, Thomas Gebel, Klaus Golka, Claudia Röhl, Thomas Schupp, Klaus‐Michael Wollin, Jan G. Hengstler	58
13	Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma 2015 ·Clinical Epigenetics ·(unknown), Sabrina Ehnert, (unknown), (unknown), Georg Damm, Daniel Seehofer, Wolfgang E. Thasler, Steven Dooley, Hossein Baharvand, Bence Sipos, Andreas K. Nüssler	52
14	Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a HumanIn VitroLiver Model: An Approach to Study DILI 2015 ·Mediators of Inflammation ·Victoria Kegel, (unknown), Britta Burkhardt, (unknown), Katrin Zeilinger, Andreas K. Nüssler, Daniel Seehofer, Georg Damm	37
15	Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling 2014 ·Blood ·Katarzyna Mleczko‐Sanecka, (unknown), (unknown), (unknown), Flavia D’Alessio, Anan Ragab, Philip E. Lapinski, Ramesh Ummanni, Ulrike Korf, Christopher C. Oakes, Georg Damm, Lorenza A. D’Alessandro, Ursula Klingmüller, Philip D. King, Michael Boutros, Matthias W. Hentze, Martina U. Muckenthaler	59
16	Isolation, characterization, and cultivation of human hepatocytes and non-parenchymal liver cells 2014 ·Experimental Biology and Medicine ·(unknown), Victoria Kegel, Katrin Zeilinger, Jan G. Hengstler, Andreas K. Nüssler, Daniel Seehofer, Georg Damm	8
17	The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage 2013 ·SHILAP Revista de lepidopterología ·Sabrina Ehnert, (unknown), Anastasia Bachmann, (unknown), Georg Damm, (unknown), (unknown), (unknown), Steven Dooley, Stefan O. Mueller, (unknown)	2
18	Direct Transcriptional Regulation of Human Hepatic Cytochrome P450 3A4 (CYP3A4) by Peroxisome Proliferator–Activated Receptor Alpha (PPARα) 2013 ·Molecular Pharmacology ·Maria Thomas, Oliver Burk, (unknown), Benjamin A. Kandel, Georg Damm, Thomas S. Weiß, Kathrin Klein, Matthias Schwab, Ulrich M. Zanger	73
19	Human parenchymal and non-parenchymal liver cell isolation, culture and characterization 2013 ·Hepatology International ·Georg Damm, (unknown), Britta Burkhardt, (unknown), Andreas K. Nüssler, Thomas S. Weiß	30
20	In vitromammalian metabolism of the mitosis inhibitor zoxamide and the relationship to itsin vitrotoxicity 2009 ·Xenobiotica ·Franz Oesch, M. Metzler, Eric Fabian, Hennicke Kamp, (unknown), Georg Damm, (unknown), (unknown), Robert Landsiedel, Bennard van Ravenzwaay	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact